These findings highlight the recently identified role of C5a-C5aR in metabolic disorders such as obesity, while supporting an anti-inflammatory role for C5aR antagonists in animal models of inflammatory diseases [41, 42]. Here, C5AR1 is linked to obesity due to melanocortin 4 receptor deficiency.